IRVINE, Calif., May 21, 2018 /PRNewswire/ -- Inari Medical, Inc., announced today the FlowTriever System has received FDA 510(k) clearance for the treatment of pulmonary embolism ("PE"). This ...
IRVINE, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the ...
Shares of Inari Medical Inc. established a new 52-week high after the company reported that preliminary revenue in Q4/20 increased year-over-year by greater than 140%. Commercial-stage medical device ...
Irvine-based Inari Medical Inc., a commercial-stage medical device company whose products treat patients suffering from blood clots and other diseases affecting veins, says the impacts of COVID-19 ...
According to the CDC, up to 600,000 Americans are diagnosed with deep vein thrombosis (DVT) or pulmonary embolisms (PE) each year. These blood clots kill between 60,000 and 100,000 people annually, ...
According to the CDC, up to 600,000 Americans are diagnosed with deep vein thrombosis (DVT) or pulmonary embolisms (PE) each year. These blood clots kill between 60,000 and 100,000 people annually, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback